Suwon-si, Gyeonggi-do, South Korea

Young Ha Park

This inventor holds 1 USPTO granted patent. Top assignee: Liveome Inc.. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Young Ha Park. Retrieved from https://idiyas.com/inventor/young-ha-park-5azadnk5

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 1.0


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Young Ha Park: Innovator in Biotechnology

Introduction

Young Ha Park is a notable inventor based in Suwon-si, Gyeonggi-do, South Korea. He has made significant contributions to the field of biotechnology, particularly in the development of microorganisms for therapeutic applications. His innovative work has led to the filing of a patent that showcases his expertise and dedication to advancing scientific knowledge.

Latest Patents

Young Ha Park holds a patent titled "Microorganism Expressing Vasoactive Intestinal Peptide, and Use Thereof." This patent highlights his research in utilizing microorganisms for potential therapeutic benefits, particularly in relation to vasoactive intestinal peptide, which plays a crucial role in various physiological processes.

Career Highlights

Currently, Young Ha Park is associated with Liveome Inc., a company focused on innovative biotechnological solutions. His role at Liveome Inc. allows him to collaborate with other experts in the field and contribute to groundbreaking research and development projects.

Collaborations

Young Ha Park works alongside his coworker, Hyo Jeong Choi, who shares a commitment to advancing biotechnological innovations. Their collaboration exemplifies the importance of teamwork in achieving significant scientific breakthroughs.

Conclusion

Young Ha Park's contributions to biotechnology through his patent and work at Liveome Inc. demonstrate his commitment to innovation and scientific advancement. His efforts in developing microorganisms for therapeutic use are paving the way for future discoveries in the field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…